OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AHC$12.1057

Aikchol Hospital PCL

Healthcare Facilities & ServicesVerified

Aikchol Hospital PCL maintains a strong liquidity position, with a current ratio of 5.89, indicating a robust ability to meet short-term obligations. The company's liquidity FPT (Free Cash Flow to Total Liabilities) is favorable, supported by a cash and equivalents balance of 229.8 million THB and a free cash flow of 138.2 million THB. The debt-to-equity ratio is 0.0, suggesting no leverage and a conservative capital structure. The company's profitability metrics are in line with industry norms. It reports a return on equity (ROE) of 7.14% and a return on assets (ROA) of 6.08%, which are reasonable for a healthcare services provider. The operating margin is 10.62% (calculated from operating income of 190.6 million THB on revenue of 1.795 billion THB), and the net profit margin is 8.56% (153.7 million THB net income on 1.795 billion THB revenue). These figures suggest the company is efficiently managing its operations and generating solid returns. Aikchol Hospital PCL operates in a single segment and geographic area, with all its revenue derived from Thailand. This concentration presents both advantages and risks. On one hand, it allows for focused operations and localized expertise. On the other hand, it exposes the company to regional economic and regulatory shifts. The company's revenue is entirely sourced from its healthcare services, with no diversification across product lines or geographic regions. The company's growth trajectory is modest but stable. Revenue for the latest period is 1.795 billion THB, and while no specific growth rate is provided, the company's operating cash flow of 205.4 million THB and free cash flow of 138.2 million THB suggest a capacity for reinvestment and expansion. The capital expenditure of -41.0 million THB indicates a reduction in capital spending, which may reflect a focus on maintaining existing operations rather than aggressive expansion. Risk factors for Aikchol Hospital PCL are minimal in the short term, with low liquidity and dilution risks identified. The company has no immediate filing-based liquidity or dilution flags, and its capital structure is free of long-term debt. However, the absence of debt also limits financial flexibility. The dilution potential is low, with no near-term pressure for share issuance, and the company's shares outstanding remain unchanged between basic and diluted measures. Recent events and filings do not indicate any material changes in the company's operations or financial position. The company continues to operate under its existing business model, with no disclosed strategic shifts or major capital projects. The most recent financial data reflects a stable and conservative approach to capital management and operations.

30-day price · AHC-1.50 (-11.3%)
Low$11.70High$14.30Close$11.80As of15 May, 00:00 UTC
Profile
CompanyAikchol Hospital PCL
TickerAHC.BK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Aikchol Hospital PCL provides full hospital services, including disease protection, medical treatment, health strengthening, and health rehabilitation, operating with 310 beds in Thailand.

Classification. Aikchol Hospital PCL is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

Aikchol Hospital PCL maintains a strong liquidity position, with a current ratio of 5.89, indicating a robust ability to meet short-term obligations. The company's liquidity FPT (Free Cash Flow to Total Liabilities) is favorable, supported by a cash and equivalents balance of 229.8 million THB and a free cash flow of 138.2 million THB. The debt-to-equity ratio is 0.0, suggesting no leverage and a conservative capital structure. The company's profitability metrics are in line with industry norms. It reports a return on equity (ROE) of 7.14% and a return on assets (ROA) of 6.08%, which are reasonable for a healthcare services provider. The operating margin is 10.62% (calculated from operating income of 190.6 million THB on revenue of 1.795 billion THB), and the net profit margin is 8.56% (153.7 million THB net income on 1.795 billion THB revenue). These figures suggest the company is efficiently managing its operations and generating solid returns. Aikchol Hospital PCL operates in a single segment and geographic area, with all its revenue derived from Thailand. This concentration presents both advantages and risks. On one hand, it allows for focused operations and localized expertise. On the other hand, it exposes the company to regional economic and regulatory shifts. The company's revenue is entirely sourced from its healthcare services, with no diversification across product lines or geographic regions. The company's growth trajectory is modest but stable. Revenue for the latest period is 1.795 billion THB, and while no specific growth rate is provided, the company's operating cash flow of 205.4 million THB and free cash flow of 138.2 million THB suggest a capacity for reinvestment and expansion. The capital expenditure of -41.0 million THB indicates a reduction in capital spending, which may reflect a focus on maintaining existing operations rather than aggressive expansion. Risk factors for Aikchol Hospital PCL are minimal in the short term, with low liquidity and dilution risks identified. The company has no immediate filing-based liquidity or dilution flags, and its capital structure is free of long-term debt. However, the absence of debt also limits financial flexibility. The dilution potential is low, with no near-term pressure for share issuance, and the company's shares outstanding remain unchanged between basic and diluted measures. Recent events and filings do not indicate any material changes in the company's operations or financial position. The company continues to operate under its existing business model, with no disclosed strategic shifts or major capital projects. The most recent financial data reflects a stable and conservative approach to capital management and operations.
Key takeaways
  • Aikchol Hospital PCL maintains a strong liquidity position with a current ratio of 5.89 and no long-term debt.
  • The company's profitability metrics, including ROE of 7.14% and ROA of 6.08%, are in line with industry norms.
  • All revenue is generated from a single geographic area (Thailand), which presents both operational focus and regional risk.
  • The company's growth is modest, with stable operating cash flow and a reduction in capital expenditures.
  • Low liquidity and dilution risks are identified, with no immediate filing-based flags.
  • The company's conservative capital structure and stable operations suggest a low-risk profile for investors.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyTHB
Revenue$1.79B
Gross profit$367.6M
Operating income$190.6M
Net income$153.7M
R&D
SG&A
D&A
SBC
Operating cash flow$205.4M
CapEx-$41.0M
Free cash flow$138.2M
Total assets$2.53B
Total liabilities$375.9M
Total equity$2.15B
Cash & equivalents$229.8M
Long-term debt$10.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$12.10
Market cap$1.81B
Enterprise value$1.59B
P/E11.8
Reported non-GAAP P/E
EV/Revenue0.9
EV/Op income8.4
EV/OCF7.8
P/B0.8
P/Tangible book0.8
Tangible book$2.15B
Net cash$219.8M
Current ratio5.9
Debt/Equity0.0
ROA6.1%
ROE7.1%
Cash conversion1.3%
CapEx/Revenue-2.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Pharmaceuticals · cohort 25 companies
MetricAHCActivity
Op margin10.6%18.2% medp25 18.2% · p75 24.6%bottom quartile
Net margin8.6%14.7% medp25 11.7% · p75 28.1%bottom quartile
Gross margin20.5%19.7% medp25 19.7% · p75 39.8%above median
R&D / revenue24.3% medp25 6.6% · p75 24.3%
CapEx / revenue-2.3%4.9% medp25 4.2% · p75 6.3%bottom quartile
Debt / equity0.0%71.3% medp25 19.0% · p75 91.7%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 04:54 UTC#7e4c333b
Market quoteclose THB 12.10 · shares 0.15B diluted
no public URL
2026-05-10 04:54 UTC#20626b63
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 04:56 UTCJob: cf7958fd